Gabapen

Gabapen may be available in the countries listed below.

Ingredient matches for Gabapen

Gabapentin

Gabapentin is reported as an ingredient of Gabapen in the following countries:

• Bangladesh


• Dominican Republic


• Greece

International Drug Name Search

Sildenafil Sandoz

Sildenafil Sandoz may be available in the countries listed below.

Ingredient matches for Sildenafil Sandoz

Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Sildenafil Sandoz in the following countries:

• Argentina

International Drug Name Search

Yisafer

Yisafer may be available in the countries listed below.

Ingredient matches for Yisafer

Ferrous Gluconate

Ferrous Gluconate is reported as an ingredient of Yisafer in the following countries:

• Venezuela

International Drug Name Search

Cunicoxil

Cunicoxil may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cunicoxil

Sulfadimethoxine

Sulfadimethoxine is reported as an ingredient of Cunicoxil in the following countries:

• France

International Drug Name Search

Drithocreme Topical

Generic Name: anthralin (Topical route)

AN-thra-lin

Commonly used brand name(s)

In the U.S.

• Drithocreme


• Dritho-Scalp


• Psoriatec


• Zithranol-RR

In Canada

• Anthraforte 2%


• Anthraforte 3%


• Anthrascalp

Available Dosage Forms:

• Paste


• Ointment


• Cream

Therapeutic Class: Antipsoriatic

Uses For Drithocreme

Anthralin is used to treat psoriasis. It may also be used to treat other skin conditions as determined by your doctor.

In the U.S., this medicine is available only with your doctor's prescription.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, anthralin is used in certain patients with the following medical condition:

• Alopecia areata (patchy hair loss)

Before Using Drithocreme

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of anthralin in children with use in other age groups.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of anthralin in the elderly with use in other age groups.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Skin diseases or problems (other)—Anthralin may make the condition worse

Proper Use of anthralin

This section provides information on the proper use of a number of products that contain anthralin. It may not be specific to Drithocreme. Please read with care.

Keep this medicine away from the eyes and mucous membranes, such as the mouth and the inside of the nose.

Do not apply this medicine to blistered, raw, or oozing areas of the skin or scalp.

Do not use this medicine on your face or sex organs or in the folds and creases of your skin. If you have any questions about this, check with your doctor.

Use this medicine only as directed. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may increase the chance of side effects.

Anthralin may be used in different ways. In some cases, it is applied at night and allowed to remain on the affected areas overnight, then washed off the next morning or before the next application. In other cases, it may be applied and allowed to remain on the affected areas for a short period of time (usually 10 to 30 minutes), then washed off. (This is called short contact treatment.) Make sure you understand exactly how you are to use this medicine. If you have any questions about this, check with your doctor.

Anthralin may cause irritation of normal skin. If it does, petrolatum may be applied to the skin or scalp around the affected areas for protection.

Apply a thin layer of anthralin to only the affected area of the skin or scalp and rub in gently and well.

Immediately after applying this medicine, wash your hands to remove any medicine that may be on them.

For patients using anthralin for short contact (usually 10 to 30 minutes) treatment:

• After applying anthralin, allow the medicine to remain on the affected area for 10 to 30 minutes or as directed by your doctor. Then remove the medicine by bathing, if the anthralin was applied to the skin, or by shampooing, if it was applied to the scalp.

For patients using the cream form of anthralin for overnight treatment:

• If anthralin cream is applied to the skin, any medicine remaining on the affected areas the next morning should be removed by bathing.


• If anthralin cream is applied to the scalp, shampoo to remove the scales and any medicine remaining on the affected areas from the previous application. Dry the hair and, after parting, rub the cream into the affected areas. Check with your doctor to see when the cream should be removed.

For patients using the ointment form of anthralin for overnight treatment:

• If anthralin ointment is applied to the skin at night, any ointment remaining on the affected areas the next morning should be removed with warm liquid petrolatum followed by bathing.


• If anthralin ointment is applied to the scalp at night, shampoo the next morning to clean the scalp.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For psoriasis:
  
  • For cream dosage form:
    
    • Adults—Apply to the dry, affected area(s) of the skin once a day, preferably at night, or as directed by your doctor. Wash medicine off skin at the proper time.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • For ointment dosage form:
    
    • Adults—Apply to the dry, affected area(s) of the skin once a day or as directed by your doctor. Wash medicine off skin at the proper time.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Drithocreme

Anthralin may stain the skin, hair, fingernails, clothing, bed linens, or bathtub or shower. The stain on the skin or hair will wear off in several weeks after you stop using this medicine. Some ways to prevent or lessen anthralin staining include:

• Wear plastic gloves when you apply this medicine.


• Avoid getting the medicine on your clothing or on bed linens. Ask your doctor if you can wear a plastic cap while sleeping if you apply your medicine to your scalp at bedtime.


• Remove any medicine on the surface of the bathtub or shower stall by immediately rinsing it with hot water after bathing or showering. Afterwards wash the bathtub or shower stall with a household cleanser to remove any remaining deposits.

Drithocreme Side Effects

Anthralin has been shown to cause tumors in animals. However, there have been no reports of anthralin causing tumors in humans.

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur:

More common

• Redness or other skin irritation of treated or uninvolved skin not present before use of this medicine

Rare

• Skin rash

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Drithocreme Topical resources

• Drithocreme Topical Use in Pregnancy & Breastfeeding
• Drithocreme Topical Support Group
• 0 Reviews for Drithocreme Topical - Add your own review/rating

Compare Drithocreme Topical with other medications

• Psoriasis

Slipiren

Slipiren may be available in the countries listed below.

Ingredient matches for Slipiren

Lorazepam

Lorazepam is reported as an ingredient of Slipiren in the following countries:

• Italy

International Drug Name Search

Taclonex Scalp

See also: Generic Taclonex

Taclonex Scalp is a brand name of betamethasone/calcipotriene topical, approved by the FDA in the following formulation(s):

TACLONEX SCALP (betamethasone dipropionate; calcipotriene hydrate - suspension; topical)

• 
  Manufacturer: LEO PHARM PRODS
  
  Approval date: May 9, 2008
  
  Strength(s): 0.064%;0.005% ^[RLD]

Has a generic version of Taclonex Scalp been approved?

No. There is currently no therapeutically equivalent version of Taclonex Scalp available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Taclonex Scalp. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical composition
  Patent 6,753,013
  Issued: June 22, 2004
  Inventor(s): Erik; Didriksen & Gert; Høy
  Assignee(s): Leo Pharmaceutical Products, Ltd. A/S
  A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticosteroid, wherein the difference between the maximum stability pH of said first component A and the maximum stability pH of said second component B is at least 1. The composition can also have at least one solvent component C, where component C is compounds of the general formula R3 (OCH2C(R1)H)xOR2 (I), wherein x is in the range of 2-60, R1 in each of the x units independently is H or CH3, R2 is straight chain or branched C1-20alkyl or benzoyl, and R3 is H or phenylcarbonyloxy; di-(straight or branched)-C4-10alkyl esters of C4-C8dicarboxylic acids; straight or branched C12-18-alkyl benzoates; straight or branched C2-4-alkyl esters of straight or branched C10-18-alkanoic or -alkenoic acids; propylenglycol diesters with C8-14-alkanoic acids; and branched primary C18-24alkanols.
  
  Patent expiration dates:
  
  
  • January 27, 2020
    
    ✓ 
    Patent use: PSORIASIS
    ✓ 
    Drug product
  
  
  
  • January 27, 2020
    
    ✓ 
    Patent use: TREATMENT OF MODERATE PLAQUE PSORIASIS
    ✓ 
    Drug product
  
  



• 
  Topical composition
  Patent 6,787,529
  Issued: September 7, 2004
  Inventor(s): Gert; Høy & Erik Johannes; Didriksen
  Assignee(s): Leo Pharmaceutical Products Ltd. A/S
  The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid as well as a viscosity-increasing excipient.
  
  Patent expiration dates:
  
  
  • January 27, 2020
    
    ✓ 
    Patent use: TREATMENT OF MODERATE PLAQUE PSORIASIS
    ✓ 
    Drug product
  
  
  
  • January 27, 2020
    
    ✓ 
    Patent use: PSORIASIS
    ✓ 
    Drug product
  
  



• 
  Crystalline form of a vitamin D analogue
  Patent RE39706
  Issued: June 26, 2007
  Inventor(s): Hansen; Erik Torngaard & Andersen; Niels Smidt Rastrup & Ringborg; Lene Hoffmeyer
  Assignee(s): Leo Pharma A/S
  The present invention relates to calcipotriol hydrate—a new crystalline form of calcipotriol—with superior technical properties and with superior stability.
  
  Patent expiration dates:
  
  
  • June 9, 2015
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • May 9, 2011 - NEW DOSAGE FORM
  
  

See also...

• Taclonex Scalp Suspension Consumer Information (Wolters Kluwer)
• Taclonex Scalp topical Consumer Information (Cerner Multum)
• Taclonex Scalp Advanced Consumer Information (Micromedex)
• Betamethasone/Calcipotriene Ointment Consumer Information (Wolters Kluwer)
• Betamethasone/Calcipotriene Suspension Consumer Information (Wolters Kluwer)
• Betamethasone and calcipotriene topical Consumer Information (Cerner Multum)
• Betamethasone and calcipotriene Topical application Advanced Consumer Information (Micromedex)

Nevirapox

Nevirapox may be available in the countries listed below.

Ingredient matches for Nevirapox

Nevirapine

Nevirapine is reported as an ingredient of Nevirapox in the following countries:

• Peru

International Drug Name Search

Alprazol

Alprazol may be available in the countries listed below.

Ingredient matches for Alprazol

Alprazolam

Alprazolam is reported as an ingredient of Alprazol in the following countries:

• Argentina

International Drug Name Search

Omeprazol Vir

Omeprazol Vir may be available in the countries listed below.

Ingredient matches for Omeprazol Vir

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Vir in the following countries:

• Spain

International Drug Name Search

Buterol

Buterol may be available in the countries listed below.

Ingredient matches for Buterol

Bambuterol

Bambuterol is reported as an ingredient of Buterol in the following countries:

• Bangladesh

Bambuterol hydrochloride (a derivative of Bambuterol) is reported as an ingredient of Buterol in the following countries:

• Bangladesh

International Drug Name Search

Irinostad

Irinostad may be available in the countries listed below.

Ingredient matches for Irinostad

Irinotecan

Irinotecan hydrochloride trihydrate (a derivative of Irinotecan) is reported as an ingredient of Irinostad in the following countries:

• Austria

International Drug Name Search

Gabapentin beta

Gabapentin beta may be available in the countries listed below.

Ingredient matches for Gabapentin beta

Gabapentin

Gabapentin is reported as an ingredient of Gabapentin beta in the following countries:

• Germany

International Drug Name Search